Abstract
Cushing's disease (CD) is a rare disorder caused by an adrenocorticotropic hormone (ACTH)-secreting pituitary adenoma. Chronic exposure to hypercortisolism leads to significant morbidities, which may be only partially reversible after remission of the disease, as well as to impairment of the health-related quality of life (HRQoL) and an increase in mortality. Transsphenoidal surgery (TSS) is the treatment of choice, and recurrence rates vary widely, confirming the need for lifelong follow-up. This review summarises the studies performed on HRQoL, recurrence rates and morbidities in patients who have CD.
Author supplied keywords
Cite
CITATION STYLE
Huguet, I., Ntali, G., Grossman, A., & Karavitaki, N. (2015). Cushing’s disease - Quality of life, recurrence and long-term morbidity. US Endocrinology, 11(1), 55–59. https://doi.org/10.17925/use.2015.11.1.55
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.